UK SEO Rank

  In the latest trading session, Star Bulk Carriers (SBLK) closed at $23.70, marking a +1.37% move from the previous day. The stock outpaced the S&P 500's daily loss of 2.04%. - Zacks Prior to today's trading, shares of the shipping company had lost 2.05% over the past month. This has lagged the Transportation sector's loss of 1.87% and the S&P 500's loss of 1.36% in that time. Wall Street will be looking for positivity from SBLK as it approaches its next earnings report date. In that report, analysts expect SBLK to post earnings of $2.09 per share. This would mark year-over-year growth of 646.43%. Meanwhile, our latest consensus estimate is calling for revenue of $402.56 million, up 101.06% from the prior-year quarter. SBLK's full-year Zacks Consensus Estimates are calling for earnings of $5.88 per share and revenue of $1.31 billion. These results would represent year-over-year changes of +3358.82% and +89.52%, respectively. Investors might also notice rece

  In principle, when we feel fear, this emotion is very useful when it comes to escaping from dangers or potential risks. However, we must not forget that it is also a barrier that blocks us emotionally and prevents us (on many occasions) from meeting our goals. Like, for example, to undertake and achieve our goals in an unimaginable way. Depositphotos.com Taking this paradigm into account, I present different fears that entrepreneurs experience and some tips to solve them: 1. Fear of failure Image: Depositphotos.com Sometimes people limit themselves by creating barriers that become impossible to break down. The fact of having a family to support or simply not having the proper studies are some aspects by which people back down. Based on my professional experience, on many occasions, this fear is experienced by not wanting to leave the “comfort zone”. Therefore, throughout the process, it will be essential to rely on loved ones and keep in mind that in the transition from employee to e

 Entrepreneurs struggle to place that first groundbreaking sale. But even after establishing that there is a market, albeit of unknown size, selling is still very hard. Even when the offering is solid, which entrepreneurs tend to believe about their own product or service, customers may not be convinced. When you ask them, they might refer to a lack of money. Had they more money, they would buy it — but since they don’t, they won’t. Or they say they will go home and think about it. Fine, they have no obligation to buy and it is better they are convinced that they are making the right choice than that they buy and become disappointed. But how often do they actually come back after thinking about it? So it is easy for entrepreneurs to blame the scarcity of money. If customers had more money, they would be easier to convince to buy the product. Bill Gates or Jeff Bezos might not mind the expense of several hundred dollars just to try something out. Or would they? There are two fundamental

  Not only did yesterday’s post-Fed rally continue on Thursday, but it also picked up steam and left the major indices with a chance for their first positive weekly performance since the beginning of September. The Dow surged by 1.48% (or about 506 points) to 34,764.82, while the S&P jumped 1.21% to 4448.98. The NASDAQ improved 1.04% (or around 155 points) to 15,052.24. All of these indices are now up more than 2% in the past 2 days. We’re enjoying the first real rally for stocks during this difficult month of September. In fact, it’s the first time the major indices all advanced by more than 1% since July 20. And now stocks are in striking distance of snapping a two-week slump with a solid performance on Friday. (The Dow has actually been in the red for three straight weeks.) Big moves after a Fed statement are normal… and sometimes this action goes in the oppositive direction as the day before. However, investors are obviously still feeling pretty good about what they heard yeste

  Pharmaceutical firms  Pfizer  and  BioNTech said  Monday that they will seek authorization for the emergency use of their vaccine in children ages 5 to 11 in the United States, Europe and elsewhere as soon as possible. Depositphotos.com According to the  Reuters  agency, both companies assured that their vaccine induced a solid response in children aged 5 to 11 years in their Phase II / III clinical trial that coincided with what they had previously observed in people aged 16 to 25 years. In case you're interested: Pfizer Says Its COVID-19 Vaccine's Efficacy Weaken Over Time "Since July, pediatric Covid-19 cases have increased by approximately 240% in the United States, underscoring the need for public health vaccination,"  Pfizer  CEO Albert Bourla said in a  press release.  . "The results of these trials provide a solid basis for seeking authorization for our vaccine for children ages 5 to 11, and we plan to send them to the FDA and other regulators as a matt

 The number of American workers who filed for unemployment rose last week after touching a pandemic-era low in the prior week, with the spread of the Delta variant and supply chain issues weighing on the labor market recovery. First-time filings for unemployment insurance—a proxy for layoffs—came in at 332,000 for the week ending Sept. 11, a rise of 20,000 from the previous week’s revised level of 310,000, the Labor Department said in a release (pdf). The consensus forecast cited by FXStreet was for 328,000 claims. “On the face of it, it is disappointing but not entirely surprising to see a slight increase in new jobless claims given the toll taken by the Delta variant. Countering that somewhat is the decline in continuing claims to a fresh pandemic era low,” Bankrate senior economic analyst Mark Hamrick told The Epoch Times in an emailed statement. Continuing claims, which run a week behind the headline number and represent people continuing to collect benefits after earlier making an

  Texas Instruments (TXN) closed the most recent trading day at $197.50, moving +1.22% from the previous trading session. This change outpaced the S&P 500's 0.85% gain on the day. - Zacks Coming into today, shares of the chipmaker had gained 4.72% in the past month. In that same time, the Computer and Technology sector gained 1.96%, while the S&P 500 lost 0.37%. TXN will be looking to display strength as it nears its next earnings release. On that day, TXN is projected to report earnings of $2.04 per share, which would represent year-over-year growth of 40.69%. Our most recent consensus estimate is calling for quarterly revenue of $4.65 billion, up 21.73% from the year-ago period. TXN's full-year Zacks Consensus Estimates are calling for earnings of $7.86 per share and revenue of $17.94 billion. These results would represent year-over-year changes of +31.66% and +24.05%, respectively. Any recent changes to analyst estimates for TXN should also be noted by investors. The

  UnitedHealth Group (UNH) closed at $412.54 in the latest trading session, marking a -0.48% move from the prior day. This change was narrower than the S&P 500's daily loss of 0.58%. - Zacks Coming into today, shares of the largest U.S. health insurer had lost 0.64% in the past month. In that same time, the Medical sector lost 0.62%, while the S&P 500 gained 0.16%. Wall Street will be looking for positivity from UNH as it approaches its next earnings report date. On that day, UNH is projected to report earnings of $4.40 per share, which would represent year-over-year growth of 25.36%. Meanwhile, our latest consensus estimate is calling for revenue of $71.37 billion, up 9.61% from the prior-year quarter. For the full year, our Zacks Consensus Estimates are projecting earnings of $18.74 per share and revenue of $285.18 billion, which would represent changes of +11.02% and +10.91%, respectively, from the prior year. Investors might also notice recent changes to analyst estimat

  In the latest trading session, Vista Outdoor (VSTO) closed at $41.47, marking a +0.07% move from the previous day. This move lagged the S&P 500's daily gain of 0.23%. - Zacks Coming into today, shares of the maker of firearms, ammunition and accessories had lost 3.67% in the past month. In that same time, the Consumer Discretionary sector gained 1.8%, while the S&P 500 gained 0.65%. Investors will be hoping for strength from VSTO as it approaches its next earnings release. The company is expected to report EPS of $1.77, up 60.91% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $722.11 million, up 25.55% from the year-ago period. For the full year, our Zacks Consensus Estimates are projecting earnings of $6.08 per share and revenue of $2.72 billion, which would represent changes of +66.12% and +22.13%, respectively, from the prior year. Any recent changes to analyst estimates for VSTO should also be noted by inves